Introduction
============

Renal cell carcinoma (RCC) is a genitourinary malignancy. Its incidence has significantly increased[@B1], and contributed to approximately 63,990 new cases and approximately 693,000 deaths worldwide in 2017[@B2]. Among the histological subtypes of RCC, clear cell RCC (ccRCC) is the most common subtype, responsible for 75-80% of all RCC cases. The prognosis of ccRCC is determined by many factors, including age, sex, disease stage, Fuhrman nuclear grade, tumor size, molecular pathogenesis and treatment strategies. Nowadays people have realized that an integrative concept of health and disease should include the interaction of biology, psychology and sociology, which is also known as biological-psychology-social medical model[@B3]-[@B4].

Recently, results from considerable literature have disclosed that that married patients have superior survival compared to the unmarried in various cancers[@B5], such as soft tissue sarcoma[@B6], liver cancer[@B7] and colon cancer[@B8]. This interesting phenomenon arise much public attentions. It is postulated that married status could contribute to optimistic psychological, enough social support, decent incomes, healthy lifestyle and comfortable living conditions. Similarly, previous studies reported that that marital status was a prognostic factor of survival in kidney cancer patients[@B9]-[@B11]. However, all of them merely focus on all kinds of kidney cancer without differentiating pathological subtypes. As we all know, RCC is a highly heterogenous tumor, ccRCC and other subtypes (eg, papillary, chromophobe) have distinct pathologies and biological behaviors, or even different long-term survival. So conducting analysis on the survival of ccRCC and other subtypes separately might be more important and reasonable. Furthermore, previous studies had significant imbalance baseline that married people were more likely to be diagnosed at an earlier stage and receive surgery compared to the unmarried. Thus, the impact of marital status on the survival of ccRCC has not been rigorously investigated.

In this study, we conducted a comprehensive study that involved a large sample ccRCC patients diagnosed between 1973 and 2015 to explore the relationship between marital status and ccRCC survival, as well as the potential underlying mechanisms. Furthermore, we also conducted 1:1 propensity score matching (PSM) analysis, a powerful method to minimize selection bias, to created 1:1 matched cohort with well-balanced baseline characteristics. In addition, we performed Cox proportional hazards regression to explore the impact of marital status on ccRCC patients in the matched cohort.

Patients and Methods
====================

Patient selection
-----------------

Our study used the SEER database-18 cohort database \[Incidence -SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2017 Sub (1973-2015 varying)\], released in November 2017, as data source[@B12]. We got access to the SEER database with the ID number 13264-Nov2017. Using the SEER-stat software (SEER\*Stat 8.2.1), patients with ICD-O-3 (International Classification of Diseases for Oncology, 3rd edition) site code C64.9 diagnosed between 1973 and 2015 were identified from the SEER database. Patients were included according to the following criteria: (1) their ICD-O-3 morphology code indicated ccRCC; (2) they aged more than 18 years at diagnosis; (3) their marital status were known; (4) they were diagnosed with ccRCC only or more than one primary cancer but ccRCC was the first; (5) their cause of death was known; (6) their survival time were known and greater than 0 month.

Study variables
---------------

The sex, age, race, diagnosis year, pathological grade, marital status, AJCC stage, surgery status, median household income, insurance status, cause of death, vital status and survival time from the SEER database. Marital status was categorized as married, divorced, single and widowed. Additionally, marital status was also categorized as married and unmarried (single, divorced and widowed) groups in the 1:1 PSM analysis. Patients were divided into three groups: 18 to 49 years, 50 to 59 years, 60 to 69 years, 70 to 79 years, and**≥**80 years. Race was classified as white, black, or others (American Indian/AK Native, Asian/Pacific Islander). Diagnosis years were divided into three periods (1973-1993,1994-2004, and 2005-2015) to eliminate the survival benefits brought by targeted therapy in recent years. County-level median household income was included to represent patients\' socioeconomic status and stratified into quintiles for analysis: Quartile 1 (\<US \$48700), Quartile 2 (US \$48701-56200), Quartile 3 (US \$56201-66931), and Quartile 4 (\>US \$66931). The included patients were furthermore stratified into "insured", "uninsured" and "unknown" groups according to their insurance status. Tumor stage were listed as stage I, stage II, stage III, stage IV according to the American Joint Committee on Cancer staging (AJCC sixth edition).

Statistical analyses
--------------------

The demographic and clinical data were presented by percentage (%). Differences in baseline characteristics were compared by χ2 test. The primary endpoints in our study, overall survival (OS) and cancer-specific survival (CSS), were calculated by Kaplan-Meier method and log-rank test was used to detect survival differences. Multivariate Cox regression analysis were performed to identify the independent prognostic factors for ccRCC patients.

To further control for potential baseline confounding factors across groups, we carried out 1:1 PSM analysis based on marital status (married and unmarried group) to re-examine the impact of marital status. In our study, a 1:1 pair matching (without replacement) was conducted through nearest neighbor method with a caliper of 0.1 times the standard deviation of the propensity score[@B13]. The matching was performed by the MatchIt package in R (version 3.5.1). Standardized differences (SD) were used to examine the balance across baseline covariates before and after matching, and a SD below 0.1 was reliable enough to provide well-balanced covariates after matching[@B14].

All statistical analyses and figures were generated using the tableone, rms, survival, survminer, ggplot2 and MatchIt packages in R (version 3.5.1), unless otherwise specified. All *p* values were two-sided with statistical significance defined at \< 0.05.

Results
=======

Patient baseline characteristics
--------------------------------

A total of 68599 eligible patients diagnosed from 1973 to 2015 in the SEER database were included. 43271 (63.08%) were male and 25328 (36.92%) were female, 44553 (64.95%) were married, 7410 (10.80%) were divorced, 10663 (15.54%) were single, and 5973 (8.71%) widowed. Baseline characteristics of ccRCC patients according to marital status were listed in Table [1](#T1){ref-type="table"}. Difference of baseline characteristics were noticed significantly in all subgroups. Especially, married group had the highest percentage of male patients (69.2%) and white patients (83.3%), while among unmarried patients, single group had the highest percentage of male patients (63.3%) and widowed group had the highest percentage of female (72.6%). Widowed patients tended to be in age groups of 60-69 (25.8%), 70-79 (39.3%), and ≥ 80 years (26.3%), while the single patients were predominantly in younger age group of 18-49 (33.4%), and more tended to present with smaller tumor sizes (54.7%) and early stages (65.2%), compared to other unmarried groups.

Impact of marital status on overall survival (OS)
-------------------------------------------------

The OS of ccRCC patients was calculated by Kaplan-Meier method. The results showed a significant survival difference according to marital status (log-rank test *p \<* 0.001) (Figure [1](#F1){ref-type="fig"}A). The 5-year OS was 79.0% in the married group, 73.8% in the divorced group, 77.3% in the single group, and 66.4% in the widowed group (*p \<* 0.001). Univariate analysis identified marital status, age, race, diagnosis year, histological type, pathological grade, tumor size, AJCC stage, surgery status, median household income and insurance status as significant factors associated with OS (*p* \< 0.001). After controlling for above-mentioned factors, multivariate Cox regression analysis showed that, compared to the married (as the reference group), divorced (hazard ratio (HR), 1.33, 95% confidence interval (CI): 1.27-1.40), single (HR, 1.26, 95%CI: 1.20-1.32), and widowed (HR, 1.42, 95%CI: 1.35-1.49) patients had higher death risks for OS (Table [2](#T2){ref-type="table"}). In addition, widowed patients had the lowest rate and the highest death risks for OS. Notably, socioeconomic factors including median household income and insurance status were significantly associated with OS in both univariate and multivariate analysis.

Impact of marital status on cancer-specific survival (CSS)
----------------------------------------------------------

The 5-year CSS rates for married patients, divorced, widowed, single patients were 85.5%, 83.3%, 80.8%, 76.5%, respectively (*p* \< 0.001) (Figure [1](#F1){ref-type="fig"}B, Table [3](#T3){ref-type="table"}). By univariate analysis, all the baseline characteristics were found to be associated with CSS among ccRCC patients. In addition, patients with insurance had better CSS than those without (5-year CSS rate 85.2 % vs. 83.2%, *p* \< 0.001). When the aforementioned covariates were adjusted in multivariate Cox regression analysis, marital status was confirmed as an independent prognostic factor, with worse CSS among unmarried patients (divorced, HR, 1.16, 95% CI 1.08-1.25, *p* \< 0.001; single, HR, 1.09, 95% CI 1.02-1.16, *p* = 0.006; widowed, HR, 1.20, 95% CI 1.13-1.28, *p* \< 0.001). However, multivariate Cox regression analysis did not support the association between insurance status and CSS (HR, 1.04, 95% CI 0.96-1.14 6,*p* = 0.314).

Subgroup analysis stratified by sex, surgery, and cancer stage
--------------------------------------------------------------

Multiple variables including have been identified as prognostic factors for ccRCC mortality, and those variables also been verified independently in our study. Hence, subsequently we divided all ccRCC patients into several subgroups stratified by those variables and investigated their impacts on CSS. The survival curves of the patients within sex, surgery and AJCC stage group were shown in Figure [2](#F2){ref-type="fig"}, Figure [3](#F3){ref-type="fig"} and Figure [4](#F4){ref-type="fig"}, respectively. Marital status remained an independent prognostic factor in almost all subgroups (*p* \< 0.001) (Table [4](#T4){ref-type="table"}). Furthermore, in the Cox regression analysis, we also observed several interesting findings: 1) The widowed patients suffered the worst CSS in each sex, surgery and AJCC stage subgroups, and being widowed was associated with the highest death risks compared to other unmarried status. 2) Being divorced would raise death risks in comparison to being married in males, patients with surgery, and all AJCC stages. 3) No significant survival differences were noticed between the married and single group in the subgroup of female, and stage II stage III.

Survival analysis of ccRCC patients in the 1:1 matched cohort
-------------------------------------------------------------

To eliminate influences of confounding factors across the baseline characteristics and ensure our observations were reliable and stable, we conducted a 1:1 matched cohort analysis through PSM method. After matching, we had 18028 ccRCC patients including 9014 married and another 9014 unmarried patients in our subsequent analysis. Distribution of the baseline characteristics was well-balanced in the matched cohort (Table [5](#T5){ref-type="table"}). In general, an absolute SD \< 0.10 indicated a negligible difference across the groups; and the largest SD was 0.03 in the matched cohort.

Even so, unmarried patients persisted to suffer more significant survival disadvantages than married patients in the Kaplan-Meier analysis. The 5-year OS rate in married patients was 75.8% while 5-year OS rate was 68.3% in unmarried group (*p* \< 0.001) (Figure [5](#F5){ref-type="fig"}A). Like OS, the 5-year CSS rate was 84.4% in the married group and 80.7% in unmarried group (*p* \< 0.001) (Figure [5](#F5){ref-type="fig"}B). Despite the basically comparable variables across two groups, we furthermore performed univariate Cox regression to make a more accurate conclusion.

Using married patients as reference, unmarried individuals persisted to be associated with increased risks death for both OS (HR, 1.31, 95%CI 1.24-1.38, *p* \< 0.001) and CSS (HR, 1.19, 95%CI 1.11-1.28, *p* \< 0.001). These results proved that our analysis was credible and reliable, which meant that the confounding factors were not responsible for the error source.

Discussion
==========

To our best knowledge, this study is the first and largest study to date investigating the impact of marital status on the survival of ccRCC patients. In this large, population-based study, we firstly used a systematic PSM and subgroup analysis to show that marital status was an independent prognostic factor and contributed to worse OS and CSS for unmarried ccRCC patients. Compared to married patients, unmarried individuals, including divorced, single, and widowed, faced higher mortality risks for OS and CSS irrespective of whether or not the patients were adjusted for age, sex, race, diagnosis year, histological type, pathological grade, AJCC stage, tumor size, surgery condition, median household income or insurance status. Besides, among the unmarried, widowed patients had the best chance of dying from ccRCC even after adjustment the abovementioned variables. Moreover, in the subgroup analysis, the increased mortality risks were also significant among unmarried patients at each sex, surgery condition, and all cancer stages subgroups. Even in the 1:1 matched cohort with comparable baseline characteristics, unmarried status still contributed to worse survival for ccRCC patients.

More importantly, our study identified several additional associations. Like, ccRCC tended to occur in young adults, more male than female, and male ccRCC patients benefited more from marriage than females. A potential reason for this sex disparity is that male patients might receive more social supports and assistance from their relatives or friends[@B15]. Interestingly, studies have suggested that the socioeconomic status is associated with better prognosis in several cancers[@B16]-[@B18]. In our study, this trend was also observed, and the widowed group had the lowest percentage of insurance, which may partly lead to their survival disadvantages. Additionally, it has been pointed that delayed diagnosis could contribute to poor survival among unmarried patients [@B8],[@B19]. However, in our study, incidence of early stage (stage I/II) cancer was higher in the single group (65.2%), divorced (64.8%), and widowed (63.2%) groups, compared with the married (64.1%). Though, the SEER database does not provide information regarding cancer screening results, earlier diagnosis for unmarried people may indicate higher odds for cancer screening. Obviously, for ccRCC patients, delayed diagnosis alone couldn\'t explain the worse survival.

Our results indicated that unmarried patients experienced a significant survival disadvantage over their unmarried counterparts. Despite unclear mechanisms intrinsic mechanisms behind this association, we try to analyze several possible reasons. First of all, people in good marital condition may be encouraged by their spouse to regular physical check-up. Moreover, married patients usually has better tolerance and adherence to prescribed treatments due to the medication reminders and assistance for their spouses[@B20], which is crucial to improve the curability rate and survival[@B21]-[@B23]. Secondly, married patients usually possess stronger financial resources such as higher income level, better employment, medical insurance, which ultimately affect the access to early prevention, timely diagnosis and treatment[@B24].

Thirdly, emotional support from spouse and other family members also contributed to better prognosis[@B25] compared to unmarried counterparts, unmarried patients, especially the widowed, have to face with higher psychological stress, economic pressures, lack of family support, absence of public assistance policy, leading to psychological imbalance, feel distressful and depressed. Multiple studies have confirmed that depression and stress were strongly associated with carcinoma growth and metastasis[@B26]-[@B28]. In addition, excess stress and depression would dysregulate the immune and endocrine function, induce chronic inflammation and thus result in worse survival[@B29]-[@B31].

In our study, approximately 73% widowed patients were female. Miller et.al have reported that natural killer cells decreased significantly in women whose husbands have died recently[@B28]. And significantly higher proportion of psychological disturbance have been found in widowed patients. It is rather intuitive that lack of social support could seriously damage the function of immune cells, leading immune escape in tumor cells. On the other hand, it has been proposed that widowed patients less tended to receive surgery compared with the married. And undertreatment could have been one explanation for poor survival in widowed patients[@B22]. This correlation between marital status and receipt of surgery was independently validated in ccRCC patients in our study. Spouses of these married individuals might encourage them to receive surgery rather than conservative treatment, which could in part account for survival discrepancies.

Our study used a large sample size and sophisticated statistical analysis to investigate in depth the impact of marital status on survival for ccRCC patients, to ensure reliability. However, some potential limitations cannot be ignored. Firstly, we just simply divided patients into the married and unmarried groups but failed to get more details about their marriage. For example, SEER database do not provide information about marital history, family problems, lifestyle factors, which may serve as potential confounding factors. Secondly, the marital status was recorded only when diagnosed and we might put some patients into the wrong group when their marital status had changed during the follow-up. In addition, for unrecorded marital status (gay, lesbian, bisexual and transgender), we can\'t rule out that some have regular partner and get social support secretly. Thirdly, as far as the whole population concerned, a predominance of white people was observed in our study. Several studies have showed that racial disparities could lead to various prognoses among ccRCC patients[@B32]-[@B34]. One final but important point, SEER database does not provide several important clinical information regarding the treatment plan, co-morbid diseases and prognostic biomarkers such as VHL, HIF-α and ALDH2, which had proven to have an effect on RCC patient prognosis[@B35].

Conclusion
==========

Marital status was an independent prognostic factor of survival for ccRCC patients. Unmarried patients faced higher mortality risks for overall and cancer-specific survival, and among these patients, the widowed suffered the highest mortality risks. Unfavorable socioeconomic and psychological status might be responsible for the inferior survival of unmarried patients.
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###### 

Baseline characteristics of ccRCC patients according to marital status in the SEER database

  --------------------------------------------------------------------------------------------------------------
  Characteristic                Total (%)     Married (%)   Divorced (%)   Single (%)    Widowed (%)   \
                                                                                                       *p*
  ----------------------------- ------------- ------------- -------------- ------------- ------------- ---------
  **Sex**                                                                                              \<0.001

  Male                          43271(63.1)   30817(69.2)   4063(54.8)     6755(63.3)    1636(27.4)    

  Female                        25328(36.9)   13736(30.8)   3347(45.2)     3908(36.7)    4337(72.6)    

  **Age**                                                                                              \<0.001

  18-49                         12230(17.8)   7356(16.5)    1236(16.7)     3557(33.4)    81(1.4)       

  50-59                         16827(24.5)   11062(24.8)   2218(29.9)     3115(29.1)    432(7.2)      

  60-69                         22019(32.1)   15190(34.1)   2632(35.5)     2653(24.9)    1544(25.8)    

  70-79                         13322(19.4)   8774(19.7)    1113(15.1)     1085(10.2)    2350(39.3)    

  ≥80                           4201(6.2)     2171(4.9)     211(2.8)       253(2.4)      1566(26.3)    

  **Race**                                                                                             \<0.001

  White                         55394(80.8)   37131(83.3)   5842(78.8)     7515(70.5)    4906(82.1)    

  Black                         8030(11.7)    3820(8.6)     1168(15.8)     2350(22.0)    692(11.6)     

  Others^1^                     5175(7.5)     3602(8.1)     400(5.4)       798(7.5)      375(6.3)      

  **Diagnosis year**                                                                                   \<0.001

  1973-1993                     15843(23.1)   10490(23.5)   1547(20.9)     1890(17.7)    1916(32.1)    

  1994-2004                     26157(38.1)   17037(38.3)   2894(39.1)     4079(38.3)    2147(35.9)    

  2005-2015                     26599(38.8)   17026(38.2)   2969(40.0)     4694(44.0)    1910(32.0)    

  **Pathological grade**                                                                               \<0.001

  Grade I                       8446(12.3)    5368(12.0)    893(12.1)      1320(12.4)    865(14.5)     

  Grade II                      34890(50.9)   22638(50.8)   3821(51.6)     5385(50.5)    3046(51.0)    

  Grade III                     20046(29.2)   13191(29.6)   2101(28.4)     3154(29.6)    1600(26.8)    

  Grade IV                      5217(7.6)     3356(7.6)     595(7.9)       804(7.5)      462(7.7)      

  **AJCC stage**                                                                                       \<0.001

  Stage I                       44110(64.3)   28580(64.1)   4803(64.8)     6952(65.2)    3775(63.2)    

  Stage II                      6822(9.9)     4402(9.9)     727(9.8)       1129(10.6)    564(9.4)      

  Stage III                     11165(16.3)   7378(16.6)    1141(15.4)     1587(14.9)    1059(17.8)    

  Stage IV                      6502(9.5)     4193(9.4)     739(10.0)      995(9.3)      575(9.6)      

  **Tumor size**                                                                                       \<0.001

  ≤5 cm                         37587(54.8)   24464(54.9)   4056(54.7)     5836(54.7)    3231(54.1)    

  5-10cm                        23197(33.8)   15044(33.8)   2533(34.2)     3487(32.7)    2133(35.7)    

  \>10 cm                       7815(11.4)    5045(11.3)    821(11.1)      1340(12.6)    609(10.2)     

  **Surgery**                                                                                          \<0.001

  Performed                     66507(96.9)   43459(97.5)   7131(96.2)     10283(96.4)   5634(94.3)    

  Not Performed                 2092(3.1)     1094(2.5)     279(3.8)       380(3.6)      339(5.7)      

  **Median household income**                                                                          \<0.001

  Quartile 1                    19671(28.7)   12515(28.1)   2314(31.2)     2951(27.7)    1891(31.7)    

  Quartile 2                    15614(22.8)   9958(22.4)    1638(22.1)     2634(24.7)    1384(23.1)    

  Quartile 3                    16913(24.7)   11096(24.8)   1859(25.1)     2610(24.5)    1348(22.6)    

  Quartile 4                    16401(23.8)   10984(24.7)   1599(21.6)     2468(23.1)    1350(22.6)    

  **Insurance status**                                                                                 

  Insured                       49926(72.8)   32659(73.3)   5532(74.7)     7832(73.5)    3903(65.3)    \<0.001

  Uninsured                     4836(7.1)     2779(6.2)     625(8.4)       976(9.1)      456(7.6)      

  Unknown                       13837(20.1)   9115(20.5)    1253(16.9)     1855(17.4)    1614(27.1)    
  --------------------------------------------------------------------------------------------------------------

AJCC, the American Joint Committee on Cancer

###### 

Univariate and multivariate survival analysis for evaluating the impact of marital status on the OS among ccRCC patients

  Variables                     5-year OS   Univariate analysis   Multivariate analysis                           
  ----------------------------- ----------- --------------------- ----------------------- ----------- ----------- ---------
  **Marital status**                        677                   \<0.001                                         
  Married                       79.0%                                                     Reference               
  Divorced                      73.8%                                                     1.33        1.27-1.40   \<0.001
  Single                        77.3%                                                     1.26        1.20-1.32   \<0.001
  Widowed                       66.4%                                                     1.42        1.35-1.49   \<0.001
  **Sex**                                   95.8                  \<0.001                                         
  Male                          75.6%                                                     Reference               
  Female                        79.4%                                                     0.85        0.82-0.88   0.021
  **Age**                                   3156                  \<0.001                                         
  18-49                         87.2%                                                     Reference               
  50-59                         81.7%                                                     1.32        1.24-1.41   \<0.001
  60-69                         77.1%                                                     1.71        1.61-1.82   \<0.001
  70-79                         70.3%                                                     2.55        2.39-2.72   \<0.001
  ≥80                           54.2%                                                     4.01        3.73-4.32   \<0.001
  **Race**                                  33.1                  \<0.001                                         
  White                         76.8%                                                     Reference               
  Black                         76.7%                                                     1.14        1.08-1.19   \<0.001
  Others                        79.9%                                                     0.88        0.82-0.93   \<0.001
  **Diagnosis year**                        173                   \<0.001                                         
  1973-1993                     73.6%                                                     Reference               
  1994-2004                     78.5%                                                     0.95        0.91-0.98   0.043
  2005-2015                     82.5%                                                     0.87        0.82-0.92   \<0.001
  **Pathological grade**                    6670                  \<0.001                                         
  Grade I                       85.1%                                                     Reference               
  Grade II                      84.4%                                                     0.97        0.93-1.04   0.477
  Grade III                     69.9%                                                     1.35        1.27-1.44   \<0.001
  Grade IV                      39.5%                                                     2.26        2.11-2.42   \<0.001
  **Tumor size**                            5612                  \<0.001                                         
  ≤5 cm                         86.7%                                                     Reference               
  5-10cm                        70.4%                                                     1.47        1.39-1.55   \<0.001
  \>10 cm                       50.6%                                                     1.67        1.55-1.79   \<0.001
  **AJCC stage**                            26079                 \<0.001                                         
  Stage I                       87.5%                                                     Reference               
  Stage II                      80.9%                                                     1.07        1.01-1.14   \<0.001
  Stage III                     67.0%                                                     1.79        1.71-1.88   \<0.001
  Stage IV                      18.61%                                                    6.62        6.29-6.98   \<0.001
  **Surgery**                               8574                  \<0.001                                         
  Performed                     78.70%                                                    Reference               
  Not Performed                 20.35%                                                    0.30        0.28-0.32   \<0.001
  **Median household income**               116                   \<0.001                                         
  Quartile 1                    74.9%                                                                             
  Quartile 2                    76.3%                                                     0.92        0.88-0.96   \<0.001
  Quartile 3                    78.3%                                                     0.85        0.81-0.88   \<0.001
  Quartile 4                    78.8%                                                     0.83        0.79-0.87   \<0.001
  **Insurance status**                      72.5                  \<0.001                                         
  Insured                       78.1%                                                     Reference               
  Uninsured                     75.4%                                                     1.16        1.07-1.25   \<0.001

AJCC, the American Joint Committee on Cancer; OS, overall survival; CI, confidence interval; HR, hazard ratio

###### 

Univariate and multivariate survival analysis for evaluating the impact of marital status on the CSS among ccRCC patients

  Variables                     5-year CSS   Univariate analysis   Multivariate analysis                             
  ----------------------------- ------------ --------------------- ----------------------- ----------- ------------- ---------
  **Marital status**                         147                   \<0.001                                           
  Married                       85.5%                                                      Reference                 
  Divorced                      83.3%                                                      1.16        1.08-1.25     \<0.001
  Single                        80.5%                                                      1.09        1.02-1.16     0.006
  Widowed                       76.5%                                                      1.20        1.13-1.28     \<0.001
  **Sex**                                    5.3                   0.021                                             
  Male                          83.8%                                                      Reference                 
  Female                        86.6%                                                      0.96        0.92-0.99     0.011
  **Age**                                    636                   \<0.001                                           
  18-49                         90.0%                                                      Reference                 
  50-59                         86.5%                                                      1.14        1.05-1.23     \<0.001
  60-69                         84.3%                                                      1.33        1.23-1.43     \<0.001
  70-79                         82.3%                                                      1.67        1.54-1.80     \<0.001
  ≥80                           74.8%                                                      2.25        2.04-2.47     \<0.001
  **Race**                                   29.7                  \<0.001                                           
  White                         84.6%                                                      Reference                 
  Black                         86.0%                                                      1.09        1.02-1.17     0.011
  Others^1^                     85.0%                                                      0.94        0.87-1.01     0.102
  **Diagnosis year**                         21                    \<0.001                                           
  1973-1993                     82.9%                                                      Reference                 
  1994-2004                     85.5%                                                      0.94        0.89-1.00     0.0431
  2005-2015                     87.7%                                                      0.84        0.79-0.90     \<0.001
  **Pathological grade**                     2085                  \<0.001                                           
  Grade I                       94.2%                                                      Reference                 
  Grade II                      92.4%                                                      1.09        0.99-1.20     0.074
  Grade III                     77.4%                                                      1.84        1.67-2.02     \<0.001
  Grade IV                      45.0%                                                      3.12        2.81-3.45     \<0.001
  **Tumor size**                             613                   \<0.001                                           
  ≤5 cm                         95.0%                                                      Reference                 
  5-10cm                        78.5%                                                      1.81        1.70-1.93     \<0.001
  \>10 cm                       55.2%                                                      2.25        2.09-2.42     \<0.001
  **AJCC stage**                             5706                  \<0.001                                           
  Stage I                       95.5%                                                      Reference                 
  Stage II                      87.8%                                                      1.59        1.45-1.74     \<0.001
  Stage III                     75.6%                                                      3.32        3.10-3.56     \<0.001
  Stage IV                      21.19%                                                     14.06       13.09-15.10   \<0.001
  **Surgery**                                4883                  \<0.001                                           
  Performed                     86.5%                                                      Reference                 
  Not Performed                 28.1%                                                      0.26        0.24-0.28     \<0.001
  **Median household income**                40.2                  \<0.001                                           
  Quartile 1                    83.9%                                                      Reference                 
  Quartile 2                    84.1%                                                      0.96        0.91-1.02     0.158
  Quartile 3                    85.3%                                                      0.88        0.83-0.93     \<0.001
  Quartile 4                    85.7%                                                      0.87        0.82-0.92     \<0.001
  **Insurance status**                       142                   \<0.001                                           
  Insured                       85.2%                                                      Reference                 
  Uninsured                     83.2%                                                      1.04        0.96-1.14     0.314

AJCC, the American Joint Committee on Cancer; CSS, cancer-specific survival; CI, confidence interval; HR, hazard ratio

###### 

Univariate and multivariate analysis of marital status on the CSS among ccRCC patients according to age, surgery status, and cancer stages

  Variables           5-year CSS   Univariate analysis   Multivariate analysis                            
  ------------------- ------------ --------------------- ----------------------- ----------- ------------ ---------
  **Sex**                                                                                                 
  **Male**                         86.5                  \<0.001                                          
  Married             84.5%                                                      Reference                
  Divorced            80.3%                                                      1.12        1.04-1.21    \<0.001
  Single              83.9%                                                      0.96        0.93-1.02    0.265
  Widowed             78.3%                                                      1.37        1.29-1.48    \<0.001
  **Female**                       122                   \<0.001                                          
  Married             87.8%                                                      Reference                
  Divorced            86.9%                                                      1.26        1.16-1.37    \<0.001
  Single              88.1%                                                      1.05        0.96-1.14    0\. 247
  Widowed             81.6%                                                      2.12        1.99-2.26    \<0.001
  **Surgery**                                                                                             
  **Performed**                    35.6                  \<0.001                                          
  Married             87.3%                                                      Reference                
  Divorced            85.5%                                                      1.52        1.29- 1.81   \<0.001
  Single              86.9%                                                      1.49        0.85-2.65    0.165
  Widowed             82.8%                                                      1.63        1.46-1.84    \<0.001
  **Not performed**                17.5                  \<0.001                                          
  Married             32.2%                                                      Reference                
  Divorced            26.8%                                                      1.16        0.98-1.36    0.066
  Single              32.3%                                                      1.02        0.84-1.24    0.834
  Widowed             24.2.2%                                                    1.28        1.04-1.71    0.015
  **AJCC stage**                                                                                          
  **Stage I**                      145                   \<0.001                                          
  Married             96.3%                                                      Reference                
  Divorced            95.8%                                                      1.35        1.25-1.47    \<0.001
  Single              96.2%                                                      1.09        1.02-1.19    \<0.001
  Widowed             92.9%                                                      2.36        2.21-2.53    \<0.001
  **Stage II**                     52.3                  \<0.001                                          
  Married             88.9%                                                      Reference                
  Divorced            84.2%                                                      1.51        1.29-1.77    \<0.001
  Single              89.6%                                                      1.14        0.98-1.33    0.088
  Widowed             79.6%                                                      2.12        1.83-2.47    \<0.001
  **Stage III**                    22.9                  \<0.001                                          
  Married             77.0%                                                      Reference                
  Divorced            72.8%                                                      1.27        1.14-1.42    \<0.001
  Single              75.2%                                                      1.09        0.99-1.21    0.0784
  Widowed             69.1%                                                      1.73        1.57-1.91    \<0.001
  **Stage IV**                     19.5                  \<0.001                                          
  Married             22.5%                                                      Reference                
  Divorced            18.9%                                                      1.11        1.02-1.22    0.021
  Single              19.0%                                                      1.14        1.05-1.23    0.002
  Widowed             18.3%                                                      1.26        1.14-1.39    \<0.001

AJCC, the American Joint Committee on Cancer; CSS, cancer-specific survival; CI, confidence interval; HR, hazard ratio

###### 

Patient baseline characteristics before and after PSM

  Characteristic                Before matching                    After matching                                                     
  ----------------------------- ----------------- ---------------- ---------------- --------- --------------- --------------- ------- ---------
  **Sample size**               **44553(100)**    **24046(100)**                              **9014(100)**   **9014(100)**           
  **Sex**                                                                           \<0.001                                           0.004
  Male                          30817(69.17)      12454(51.79)     NA                         4805(53.3)      4611(52.2)      NA      
  Female                        13736(30.83)      11592(48.21)     0.46                       4209(46.7)      4403(48.8)      0.02    
  **Age**                                                                           \<0.001                                           \<0.001
  18-49                         7356(16.5)        4874(20.3)       NA                         88(1.0)         81(0.9)         NA      
  50-59                         11062(24.8)       5765(24.0)       0.43                       2336(25.9)      2463(27.3)      0.01    
  60-69                         15190(34.1)       6829(28.4)       0.47                       4157(46.1)      3847(42.7)      -0.03   
  70-79                         8774(19.7)        4548(18.9)       0.40                       1102(12.2)      1085(12.0)      0.00    
  ≥80                           2171(4.9)         2030(8.4)        0.22                       1331(14.8)      1538(17.1)      0.02    
  **Race**                                                                          \<0.001                                           0.561
  White                         37131(83.3)       18263(76.0)      NA                         6673(74.0)      6704(74.4)      NA      
  Black                         3820(8.6)         4210(17.5)       0.28                       1733(19.2)      1682(18.7)      -0.01   
  Others                        3602(8.1)         1573(6.5)        0.27                       608(6.7)        628(7.0)        0.00    
  **Diagnosis year**                                               \<0.001                                    0.01            0.964   
  1973-1993                     10490(23.5)       5353(22.3)       NA                         10490(23.5)     5353(22.3)      NA      
  1994-2004                     17037(38.2)       9120(37.9)       0.49                       17037(38.2)     9120(37.9)      0.00    
  2005-2015                     17026(38.2)       9573(39.8)       0.49                       17026(38.2)     9573(39.8)      0.00    
  **Pathological grade**                                                            0.002                                     -0.01   0.267
  Grade I                       5368(12.0)        3078(12.8)       NA                         1086(12.0)      1093(12.1)      NA      
  Grade II                      22638(50.8)       12252(51.0)      0.50                       4568(50.7)      4509(50.0)      -0.01   
  Grade III                     13191(29.6)       6855(28.5)       0.46                       2753(30.5)      2738(30.4)      0.00    
  Grade IV                      3356 (7.5)        1861(7.7)        0.26                       607(6.7)        674(7.5)        0.01    
  **AJCC stage**                                                                                                                      0.495
  Stage I                       28580(64.1)       15530(64.6)      0.33             0.048     5769(64.0)      5680(63.0)      0.00    
  Stage II                      4402(9.9)         2420(10.1)       0.30                       883(9.8)        886(9.8)        0.00    
  Stage III                     7378(16.6)        3787(15.7)       0.37                       1521(16.9)      1563(17.3)      0.00    
  Stage IV                      4193(9.4)         2309(9.6)        0.29                       841(9.3)        885(9.8)        0.00    
  **Tumor size**                                                   0.626                                      0.01            0.196   
  ≤10 cm                        24464(54.9)       13123(54.6)      NA                         4890(54.2)      4783(53.1)      NA      
  10-20cm                       15044(33.8)       8153(33.9)       0.47                       3165(35.1)      3214(35.7)      0.01    
  \>20 cm                       5045 (11.3)       2770(11.5)       0.32                       959(10.6)       1017(11.3)      0.01    
  **Surgery**                                                      \<0.001                                                    0.601   
  Performed                     43459(97.54)      23048(95.85)     0.18                       8589(95.1)      8574(95.1)      0.00    
  Not Performed                 1094(2.46)        998(4.15)        0.15                       425(4.9)        4404.9)         0.00    
  **Median household income**                                                       \<0.001                                           0.723
  Quartile 1                    12515(28.1)       7156(29.8)       NA                         2984(33.1)      2960(32.8)      NA      
  Quartile 2                    9958 (22.4)       5656(23.5)       0.42                       2370(26.3)      2405(26.7)      0.00    
  Quartile 3                    11096(24.9)       5817(24.2)       0.43                       1905(21.1)      1943(21.6)      -0.01   
  Quartile 4                    10984(24.7)       5417(22.5)       0.43                       1755(19.5)      1706(18.9)      -0.01   
  **Insurance status**                                                              \<0.001                                           0.638
  Insured                       32659(73.3)       17267(71.8)      NA                         6374(70.7)      6430(71.3)      NA      
  Uninsured                     2779 (6.2)        2057(8.6)        0.24                       887(9.8)        876(9.7)        0.00    
  Unknown                       9115(20.5)        4722(19.6)       0.40                       1753(19.4)      1708(18.9)      0.00    

AJCC, the American Joint Committee on Cancer; SD, standardized difference; NA, not applicable. \**p* value for χ2 test.
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